Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

ARK Invest's investment thesis on Alamar Biosciences Inc. ($ALMR) — Q2 2026 | Buyside Digest

$ALMRNASDAQAlamar Biosciences Inc.

BULL

ARK Invest—ALMR

Fund Letter

Q2 2026

Published June 30, 2026

$34.07USD

+10.6% vs last month

$25.94Pitched

+31.3% since pitch

Market CapN/A

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Alamar Biosciences develops high-sensitivity life science tools and consumables focused on precision proteomics. Its proprietary NULISA...

— Catherine D. Wood

BSD Research Exclusive

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

Other investors who've written on Alamar Biosciences Inc.

No other institutional pitches found for this ticker yet.